Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function

James E Neffendorf, Tracey Mare, Andrew R H Simpson, Cristina Soare, Varo Kirthi, Claire C Sharpe, Timothy L Jackson

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
10 Downloads (Pure)

Abstract

This study did not find any clinically significant change in serum markers of renal function in the one month after intravitreal ranibizumab or aflibercept. It did, however, find a non-significant rise in creatinine with aflibercept, that was not seen with ranibizumab.
Original languageEnglish
Pages (from-to)1770-1772
Number of pages3
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Volume38
Issue number7
Early online date10 Feb 2023
DOIs
Publication statusPublished - 30 Jun 2023

Fingerprint

Dive into the research topics of 'Effect of intravitreal anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration on renal function'. Together they form a unique fingerprint.

Cite this